These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
810 related items for PubMed ID: 16397018
1. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018 [Abstract] [Full Text] [Related]
2. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines. Gu L, Chiang KY, Zhu N, Findley HW, Zhou M. Exp Hematol; 2007 Jun 01; 35(6):957-66. PubMed ID: 17533050 [Abstract] [Full Text] [Related]
3. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA. Clin Cancer Res; 2006 Jan 01; 12(1):20-8. PubMed ID: 16397019 [Abstract] [Full Text] [Related]
4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Sep 01; 117(1):45-54. PubMed ID: 18791823 [Abstract] [Full Text] [Related]
5. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity. Buettner R, Huang M, Gritsko T, Karras J, Enkemann S, Mesa T, Nam S, Yu H, Jove R. Mol Cancer Res; 2007 Aug 01; 5(8):823-32. PubMed ID: 17699108 [Abstract] [Full Text] [Related]
6. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH. Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453 [Abstract] [Full Text] [Related]
7. Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Jiang H, Yu J, Guo H, Song H, Chen S. Biochem Biophys Res Commun; 2008 Mar 28; 368(1):1-5. PubMed ID: 18242580 [Abstract] [Full Text] [Related]
8. Evaluation of potential Stat3-regulated genes in human breast cancer. Hsieh FC, Cheng G, Lin J. Biochem Biophys Res Commun; 2005 Sep 23; 335(2):292-9. PubMed ID: 16081048 [Abstract] [Full Text] [Related]
9. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S. Clin Cancer Res; 2005 Nov 01; 11(21):7674-82. PubMed ID: 16278387 [Abstract] [Full Text] [Related]
10. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T. Oncogene; 2004 Jun 17; 23(28):4921-9. PubMed ID: 15077160 [Abstract] [Full Text] [Related]
11. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Clin Cancer Res; 2006 Sep 01; 12(17):5055-63. PubMed ID: 16951221 [Abstract] [Full Text] [Related]
12. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL. Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385 [Abstract] [Full Text] [Related]
13. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers. Xia W, Bisi J, Strum J, Liu L, Carrick K, Graham KM, Treece AL, Hardwicke MA, Dush M, Liao Q, Westlund RE, Zhao S, Bacus S, Spector NL. Cancer Res; 2006 Feb 01; 66(3):1640-7. PubMed ID: 16452223 [Abstract] [Full Text] [Related]
14. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. Carcinogenesis; 2010 Feb 01; 31(2):192-200. PubMed ID: 19926637 [Abstract] [Full Text] [Related]
15. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model. Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D. J Natl Cancer Inst; 2006 Sep 06; 98(17):1238-47. PubMed ID: 16954476 [Abstract] [Full Text] [Related]
16. Growth factor-dependent regulation of survivin by c-myc in human breast cancer. Cosgrave N, Hill AD, Young LS. J Mol Endocrinol; 2006 Dec 06; 37(3):377-90. PubMed ID: 17170079 [Abstract] [Full Text] [Related]
17. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Oncogene; 2002 Mar 27; 21(13):2000-8. PubMed ID: 11960372 [Abstract] [Full Text] [Related]
18. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin. Pizzoferrato E, Liu Y, Gambotto A, Armstrong MJ, Stang MT, Gooding WE, Alber SM, Shand SH, Watkins SC, Storkus WJ, Yim JH. Cancer Res; 2004 Nov 15; 64(22):8381-8. PubMed ID: 15548708 [Abstract] [Full Text] [Related]
19. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T, Fujimori T. Carcinogenesis; 2008 Jan 15; 29(1):76-83. PubMed ID: 18024479 [Abstract] [Full Text] [Related]
20. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y. Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]